Hematological parameters predicting severity and mortality in COVID-19 patients of Pakistan: a retrospective comparative analysis
Open Access
- 29 October 2020
- journal article
- research article
- Published by Greater Baltimore Medical Center in Journal of Community Hospital Internal Medicine Perspectives
- Vol. 10 (6) , 514-520
Abstract
Background and Objectives: COVID-19 is a global pandemic. In our study, we aimed to utilize the hematological parameters in predicting the prognosis and mortality in COVID-19 patients. Materials and methods: A retrospective, observational study was conducted to include all the admitted patients (n = 191) having COVID-19 Polymerase chain reaction (PCR) positive, and evaluated those for prognosis and disease outcome by utilizing several biochemical and hematological markers. Results: Amongst the patients admitted in the ward versus in the intensive care unit (ICU), there were significant differences in mean hemoglobin (P = 0.003), total leukocyte count (P = 0.001), absolute neutrophil and lymphocyte counts (P < 0.001), absolute monocyte count (P = 0.019), Neutrophil-to-Lymphocyte ratio (NLR) and Lymphocyte-to-Monocyte ratio (LMR) (P < 0.001), Platelet-to-Lymphocyte ratio (PLR) and Lymphocyte-to C-reactive protein ratio (LCR) (P = 0.002), and C-reactive protein (CRP) levels (P < 0.001). Amongst the deceased patients, there was significant leukocytosis (P = 0.008), neutrophilia and lymphopenia (P < 0.001), increased NLR (P = 0.001), decreased LMR (P < 0.001), increased PLR (p = 0.017), decreased LCR (p = 0.003), and elevated CRP level (P < 0.001). A receiver operating characteristic curve obtained for the above parameters showed NLR (AUC: 0.841, PPV: 83.6%) and PLR (AUC: 0.703, PPV: 81.8%) for ICU patients, while NLR (AUC: 0.860, PPV: 91.1%) and PLR (AUC: 0.677, PPV: 87.5%) for the deceased patients had significant accuracy for predicting the disease severity of COVID-19 in comparison to survivors. Conclusion: The inflammatory markers and hematological indices are a good guide for predicting the severity and disease outcome of coronavirus disease. NLR and PLR are elevated in severe disease while LMR and LCR are inversely correlating with disease severity.Keywords
Funding Information
- No funding required in this study
This publication has 25 references indexed in Scilit:
- The Platelet-to-Lymphocyte Ratio as an Inflammatory Marker in Rheumatic DiseasesAnnals of Laboratory Medicine, 2019
- Combined Diagnostic Efficacy of Neutrophil-to-Lymphocyte Ratio (NLR), Platelet-to-Lymphocyte Ratio (PLR), and Mean Platelet Volume (MPV) as Biomarkers of Systemic Inflammation in the Diagnosis of Colorectal CancerDisease Markers, 2019
- Frequency of everyday pro-environmental behaviour is explained by baseline activation in lateral prefrontal cortexScientific Reports, 2019
- Association of lymphocyte to monocyte ratio with severity of coronary artery diseaseMedicine, 2018
- Neutrophil-to-lymphocyte ratio as a prognostic marker in critically-ill septic patientsResearch and Opinion in Anesthesia & Intensive Care, 2018
- The potential role of platelets in the consensus molecular subtypes of colorectal cancerCancer and Metastasis Reviews, 2017
- Comparison of Neutrophils-lymphocytes Ratio and Procalcitonin Parameters in Sepsis Patient Treated in Intensive Care Unit Dr. Wahidin Hospital, Makassar, IndonesiaJournal of Medical Sciences, 2016
- The lymphocyte-monocyte ratio in clinical practiceJournal of Clinical Pathology, 2015
- Correlation Between the Pretherapeutic Neutrophil to Lymphocyte Ratio and the Pathologic Response to Neoadjuvant Chemotherapy in Patients With Advanced Esophageal CancerWorld Journal of Surgery, 2012
- The Baseline Ratio of Neutrophils to Lymphocytes Is Associated with Patient Prognosis in Advanced Gastric CancerOncology, 2007